Back to Search Start Over

Dominant negative ATM mutations in breast cancer families

Authors :
Chenevix-Trench, G.
Spurdle, A. B.
Gatei, M.
Kelly, H.
Marsh, A.
Chen, X.
Donn, K.
Cummings, M.
Nyholt, D.R.
Jenkins, M. A.
Scott, C.
Pupo, G. M.
Dork, T.
Bendix, R.
Kirk, J.
Tucker, K.
McCredie, M. R.
Hopper, J. L.
Sambrook, J.
Mann, G. J.
Khanna, K. K.
Chenevix-Trench, G.
Spurdle, A. B.
Gatei, M.
Kelly, H.
Marsh, A.
Chen, X.
Donn, K.
Cummings, M.
Nyholt, D.R.
Jenkins, M. A.
Scott, C.
Pupo, G. M.
Dork, T.
Bendix, R.
Kirk, J.
Tucker, K.
McCredie, M. R.
Hopper, J. L.
Sambrook, J.
Mann, G. J.
Khanna, K. K.
Source :
Journal of the National Cancer Institute
Publication Year :
2002

Abstract

Free to read at publisher's site. BACKGROUND: The ATM gene encoding a putative protein kinase is mutated in ataxia-telangiectasia (A-T), an autosomal recessive disorder with a predisposition for cancer. Studies of A-T families suggest that female heterozygotes have an increased risk of breast cancer compared with noncarriers. However, neither linkage analyses nor mutation studies have provided supporting evidence for a role of ATM in breast cancer predisposition. Nevertheless, two recurrent ATM mutations, T7271G and IVS10-6T-->G, reportedly increase the risk of breast cancer. We examined these two ATM mutations in a population-based, case-control series of breast cancer families and multiple-case breast cancer families. METHODS: Five hundred twenty-five or 262 case patients with breast cancer and 381 or 68 control subjects, respectively, were genotyped for the T7271G and IVS10-6T-->G ATM mutations, as were index patients from 76 non-BRCA1/2 multiple-case breast cancer families. Linkage and penetrance were analyzed. ATM protein expression and kinase activity were analyzed in lymphoblastoid cell lines from mutation carriers. All statistical tests were two-sided. RESULTS: In case and control subjects unselected for family history of breast cancer, one case patient had the T7271G mutation, and none had the IVS10-6T-->G mutation. In three multiple-case families, one of these two mutations segregated with breast cancer. The estimated average penetrance of the mutations was 60% (95% confidence interval [CI] = 32% to 90%) to age 70 years, equivalent to a 15.7-fold (95% CI = 6.4-fold to 38.0-fold) increased relative risk compared with that of the general population. Expression and activity analyses of ATM in heterozygous cell lines indicated that both mutations are dominant negative. CONCLUSION: At least two ATM mutations are associated with a sufficiently high risk of breast cancer to be found in multiple-case breast cancer families. Full mutation analysis of the ATM gene i

Details

Database :
OAIster
Journal :
Journal of the National Cancer Institute
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn944155242
Document Type :
Electronic Resource